Zymeworks to buy Theravance Biopharma for $17 per share

June 29, 2026 6:00 AM

Zymeworks Inc. (NASDAQ: ZYME) announced it has entered into a definitive agreement to acquire Theravance Biopharma, Inc. (NASDAQ: TBPH) at ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found